Abstract:It has recently been shown that approximately 90% of cases of non-fatal myocardial infarction and many cases of sudden cardiac death are caused by disruption of a coronary atherosclerotic plaque, followed by occlusive thrombus formation. Secondly, the circadian pattern of myocardial infarction is well known to feature a prominent increase in the morning hours. Taken together, these factors may provide an opportunity to reduce deaths caused by cardiovascular disease. Findings indicate that, in many cases, plaqu… Show more
“…Conversely, a dynamic system may also be disadvantageous. For example, excessive surges in sympathetic activity, with concurrent vagal withdrawal is associated with the waking process [15], and these changes may account for the increased occurrence of adverse cardiac events towards the end of the sleep period and during wakefulness following sleep [20,24,31,32].…”
Older adults did not experience increased sympathetic dominance during morning wakefulness; thus in the older population, fluctuations in autonomic control, indicated by HRV measurements, are unlikely to account for increased occurrence of cardiac events at this time.
“…Conversely, a dynamic system may also be disadvantageous. For example, excessive surges in sympathetic activity, with concurrent vagal withdrawal is associated with the waking process [15], and these changes may account for the increased occurrence of adverse cardiac events towards the end of the sleep period and during wakefulness following sleep [20,24,31,32].…”
Older adults did not experience increased sympathetic dominance during morning wakefulness; thus in the older population, fluctuations in autonomic control, indicated by HRV measurements, are unlikely to account for increased occurrence of cardiac events at this time.
“…1 Some believe this morning excess of cardiovascular risk parallels the usual circadian pattern of physical activity, blood pressure, plasma catecholamines, and/or plasma cortisol. [2][3][4][5] Early studies of the timing of acute stroke, however, indicated that many afflicted patients reported awakening with new neurologic deficits, and several reports indicated that acute strokes tended to occur either during the evening hours or during sleep. [6][7][8] This led to the conclusion that especially because acute therapies for stroke-in-evolution were not particularly effective, there was little reason to consider acute stroke as a medical emergency because the onset of symptoms was thought to occur during sleep, when most patients would not recognize them.…”
Background and Purpose-Acute myocardial infarction and sudden death display a circadian rhythm, with a higher risk between 6 AM and noon. Some reports suggest that stroke does not follow such a circadian variation and that hemorrhagic stroke occurs more often during the evening. Methods-A meta-analysis of 31 publications reporting the circadian timing of 11 816 strokes was performed, subdividing (when possible) by the type of stroke, according to the time of onset of symptoms. When precise timing was not given, strokes were distributed evenly (that is, biasing toward the null hypothesis of lack of circadian variation). Results-All subtypes of strokes displayed a significant (PϽ0.001) circadian variation in time of onset, whether divided into 3-, 4-, or 6-hour time periods. There was a 49% increase (95% confidence interval, 44% to 55%) in stroke of all types between 6 AM and noon (compared with expectations if no circadian variation was present), which is a 79% (95% confidence interval, 72% to 87%) increase over the normalized risk of the other 18 hours of the day. There were 29% fewer strokes between midnight and 6 AM, a 35% decrease compared with the other 18 hours of the day. All three subtypes of stroke had a significantly higher risk between 6 AM and noon (55% for 8250 ischemic strokes; 34% for 1801 hemorrhagic strokes, and 50% for 405 transient ischemic attacks). Conclusions-These data support the presence of a circadian pattern in the onset of stroke, with a significantly higher risk in the morning. (Stroke. 1998;29:992-996.)
“…16 Tolerability was good during both treatment phases and there were no serious adverse events. Similar numbers of patients reported adverse events following amlodipine and lisinopril and there were 95% confidence intervals (CI) relate to differences in mean % changes in BP between treatments;…”
The anti-hypertensive efficacy of once-daily amlodipine (up to 10 mg) and lisinopril (up to 20 mg) were compared in terms of clinic and ambulatory blood pressure (BP) control, in an observer-blind, two-period crossover study. Following a 4-week placebo run-in period, patients underwent two active treatment phases each lasting 12 weeks and separated by a 4-week washout period. Sixty patients with a supine diastolic BP between 90 and 120 mm Hg were included, irrespective of whether or not they had received previous anti-hyper-
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.